Lysophosphatidic Acid Induces Podocyte Pyroptosis in Diabetic Nephropathy by an Increase of Egr1 Expression via Downregulation of EzH2
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lysophosphatidic Acid Induces Podocyte Pyroptosis in Diabetic Nephropathy by an Increase of Egr1 Expression via Downregulation of EzH2
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 24, Issue 12, Pages 9968
Publisher
MDPI AG
Online
2023-06-09
DOI
10.3390/ijms24129968
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early growth response factor 1 upregulates pro-fibrotic genes through activation of TGF-β1/Smad pathway via transcriptional regulation of PAR1 in high-glucose treated HK-2 cells
- (2023) Ping Xu et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Mechanisms of podocyte injury and implications for diabetic nephropathy
- (2022) Federica Barutta et al. CLINICAL SCIENCE
- Podocyte Injury in Diabetic Kidney Disease: A Focus on Mitochondrial Dysfunction
- (2022) Simeng Liu et al. Frontiers in Cell and Developmental Biology
- Effects of a lysophosphatidic acid receptor 1 antagonist on hypertensive renal injury in Dahl-Iwai salt-sensitive rats
- (2022) Takumi Naruse et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Podocyte-specific Nlrp3 inflammasome activation promotes diabetic kidney disease
- (2022) Khurrum Shahzad et al. KIDNEY INTERNATIONAL
- Effect of BBT-877, a novel inhibitor of ATX, on a mouse model of type 1 diabetic nephropathy
- (2022) Jong Han Lee et al. Aging-US
- Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy
- (2021) Ming Wu et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Vitamin D/VDR Protects Against Diabetic Kidney Disease by Restoring Podocytes Autophagy
- (2021) Zhixia Song et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- PodoSighter: A Cloud-Based Tool for Label-Free Podocyte Detection in Kidney Whole Slide Images
- (2021) Darshana Govind et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Epigenetic regulation of TXNIP-mediated oxidative stress and NLRP3 inflammasome activation contributes to SAHH inhibition-aggravated diabetic nephropathy
- (2021) Xin Dai et al. Redox Biology
- Lysophosphatidic Acid Mediates Imiquimod-Induced Psoriasis-like Symptoms by Promoting Keratinocyte Proliferation through LPAR1/ROCK2/PI3K/AKT Signaling Pathway
- (2021) Donghee Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- An Epigenetic Insight into NLRP3 Inflammasome Activation in Inflammation-Related Processes
- (2021) Aroa Baragaño Raneros et al. Biomedicines
- Innate immunity in diabetic kidney disease
- (2020) Sydney C. W. Tang et al. Nature Reviews Nephrology
- UHRF1 Controls Thymocyte Fate Decisions through the Epigenetic Regulation of EGR1 Expression
- (2020) Yiwen Zhang et al. JOURNAL OF IMMUNOLOGY
- NEK7: a potential therapy target for NLRP3-related diseases
- (2020) Ganglei Liu et al. BioScience Trends
- MicroRNAs in Podocyte Injury in Diabetic Nephropathy
- (2020) Hiroki Ishii et al. Frontiers in Genetics
- Lysine methylation of transcription factors in cancer
- (2019) Dong Han et al. Cell Death & Disease
- Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
- (2019) Yang Yang et al. Cell Death & Disease
- Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase
- (2019) Jong Han Lee et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Long noncoding RNA NONHSAG053901 promotes diabetic nephropathy via stimulating Egr‐1/TGF‐β‐mediated renal inflammation
- (2019) Wenfang Peng et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The PPARγ agonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3
- (2019) Ágnes Németh et al. BMC Nephrology
- Early Growth Response 1 Deficiency Protects the Host against Pseudomonas aeruginosa Lung Infection
- (2019) Zheng Pang et al. INFECTION AND IMMUNITY
- Inhibition of AIM2 inflammasome-mediated pyroptosis by Andrographolide contributes to amelioration of radiation-induced lung inflammation and fibrosis
- (2019) Jian Gao et al. Cell Death & Disease
- Early Growth Response 1 (Egr1) Is a Transcriptional Activator of NOX4 in Oxidative Stress of Diabetic Kidney Disease
- (2018) Fang Hu et al. Journal of Diabetes Research
- EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?
- (2017) Ke-Sin Yan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Transcription factor EGR1 promotes differentiation of bovine skeletal muscle satellite cells by regulating MyoG gene expression
- (2017) WeiWei Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Shifts in podocyte histone H3K27me3 regulate mouse and human glomerular disease
- (2017) Syamantak Majumder et al. JOURNAL OF CLINICAL INVESTIGATION
- Urinary lysophopholipids are increased in diabetic patients with nephropathy
- (2017) Jean-Sébastien Saulnier-Blache et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Lysophosphatidic Acid Receptor Antagonism Protects against Diabetic Nephropathy in a Type 2 Diabetic Model
- (2017) Ming-Zhi Zhang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice
- (2017) Hui Ying Li et al. KIDNEY INTERNATIONAL
- GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death
- (2016) Lorenzo Sborgi et al. EMBO JOURNAL
- K + Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting Mitochondria
- (2016) Christina J. Groß et al. IMMUNITY
- Egr-1 deficiency protects from renal inflammation and fibrosis
- (2016) Li-Chun Ho et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Caspase-1, but Not Caspase-3, Promotes Diabetic Nephropathy
- (2016) K. Shahzad et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Transcription Factor Egr1 is Involved in High Glucose-Induced Proliferation and Fibrosis in Rat Glomerular Mesangial Cells
- (2015) Dan Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The Histone Methyltransferase Enzyme Enhancer of Zeste Homolog 2 Protects against Podocyte Oxidative Stress and Renal Injury in Diabetes
- (2015) F. S. Siddiqi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Expression and Significance of NLRP3 Inflammasome in Patients with Primary Glomerular Diseases
- (2015) Jing Xiong et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
- (2015) Khurrum Shahzad et al. KIDNEY INTERNATIONAL
- Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
- (2015) Jianjin Shi et al. NATURE
- Prediction of prevalence of chronic kidney disease in diabetic patients in countries of the European Union up to 2025
- (2015) Alexander Kainz et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer
- (2015) Debashish Sahay et al. Oncotarget
- NADPH Oxidase-Induced NALP3 Inflammasome Activation Is Driven by Thioredoxin-Interacting Protein Which Contributes to Podocyte Injury in Hyperglycemia
- (2015) Pan Gao et al. Journal of Diabetes Research
- High glucose increases Cdk5 activity in podocytes via transforming growth factor-β1 signaling pathway
- (2014) Yue Zhang et al. EXPERIMENTAL CELL RESEARCH
- LPA receptor signaling: pharmacology, physiology, and pathophysiology
- (2014) Yun C. Yung et al. JOURNAL OF LIPID RESEARCH
- Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles
- (2014) Kerri J. Grove et al. JOURNAL OF LIPID RESEARCH
- Regulation and Role of EZH2 in Cancer
- (2014) Hirohito Yamaguchi et al. Cancer Research and Treatment
- Epigenetic changes in renal genes dysregulated in mouse and rat models of type 1 diabetes
- (2013) Radko Komers et al. LABORATORY INVESTIGATION
- Mechanisms of histone H3 lysine 27 trimethylation remodeling during early mammalian development
- (2012) Yanina S. Bogliotti et al. Epigenetics
- Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma
- (2011) Flavia V. Castelino et al. ARTHRITIS AND RHEUMATISM
- Regulation of chromatin by histone modifications
- (2011) Andrew J Bannister et al. CELL RESEARCH
- Pharmacokinetic and Pharmacodynamic Characterization of an Oral Lysophosphatidic Acid Type 1 Receptor-Selective Antagonist
- (2010) J. S. Swaney et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Epithelial-to-Mesenchymal Transition Is a Potential Pathway Leading to Podocyte Dysfunction and Proteinuria
- (2008) Yingjian Li et al. AMERICAN JOURNAL OF PATHOLOGY
- Stressed-out Podocytes in Diabetes?
- (2008) R. F. Spurney et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search